Reason: Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.
Distributed: NationwideReason: Failed Content Uniformity Specifications: The Spray Content Uniformity (SCU) requirement for Standard Deviation did not meet the requirement at the 18-month stability time point.
Distributed: Nationwide in the USAReason: CGMP Deviations: Potential risk of Cross Contamination
Distributed: USA nationwide.Reason: CGMP Deviations: Potential risk of Cross Contamination
Distributed: USA nationwide.Reason: CGMP Deviations: Potential risk of Cross Contamination
Distributed: USA nationwide.Reason: CGMP Deviations: Potential risk of Cross Contamination
Distributed: USA nationwide.Reason: CGMP Deviations: Potential risk of Cross Contamination
Distributed: USA nationwide.Reason: CGMP Deviations: Potential risk of Cross Contamination
Distributed: USA nationwide.Reason: CGMP Deviations
Distributed: Nationwide in the USA and Worldwide through e-commerce and trade showsReason: Non-Sterility
Distributed: Nationwide in the USA and Worldwide through e-commerce and trade shows